Matchpoint Therapeutics

About:

Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.

Website: https://matchpointtx.com/

Twitter/X: matchpointtx

Top Investors: Alexandria Venture Investments, Digitalis Ventures, Atlas Venture, Access Biotechnology, Vertex Ventures HC

Description:

Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry library evolution. Matchpoint has an emerging pipeline of novel covalent medicines, initially focused on immunology.